Help! I've fallen again and I can't get up - MS Australia
Help! I've fallen again and I can't get up - MS Australia
Help! I've fallen again and I can't get up - MS Australia
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
6<br />
<strong>MS</strong> RESEARCH<br />
<strong>MS</strong> is highly variable <strong>and</strong> unpredictable <strong>and</strong> spontaneous<br />
changes in disease can be confused for treatment<br />
benefits. So large so-called ‘Phase 3’ clinical trials in <strong>MS</strong><br />
must be carefully designed, using sufficient numbers of<br />
people who have been r<strong>and</strong>omly assigned to specific<br />
treatment gro<strong>up</strong>s. One gro<strong>up</strong> might receive the<br />
experimental therapy <strong>and</strong> another, the ‘control’ gro<strong>up</strong>,<br />
might receive either a st<strong>and</strong>ard treatment or an<br />
inactive placebo.<br />
To avoid bias introduced by the physician’s or<br />
participant’s expectations, (‘placebo effect’), most large<br />
trials are ‘blinded’ to reduce the chance that patients<br />
<strong>and</strong> examining physicians know to which gro<strong>up</strong> any<br />
individual is assigned.<br />
A statistically relevant number of participants is<br />
essential, <strong>and</strong> the study is often conducted at a number<br />
of different sites (‘multicenter’) to ensure that the agent<br />
can be used equivalently in many different settings.<br />
Different agents may have different effects on various<br />
types of <strong>MS</strong>, so trials must be designed to answer<br />
questions on a specific disease type, <strong>and</strong> care must be<br />
taken to enroll only participants who have that<br />
type of <strong>MS</strong>.<br />
Only at the end of a well-designed study, the true<br />
efficacy <strong>and</strong> safety of the new agent can be determined.<br />
At that time, if an agent seems to be effective <strong>and</strong><br />
relatively safe to use, a sponsor (usually a pharmaceutical<br />
company) will approach the relevant authorities (e.g. the<br />
US Food <strong>and</strong> Drug Administration) for approval to<br />
market the agent for <strong>MS</strong>.<br />
(With thanks to the National <strong>MS</strong> Society in the USA<br />
who published this information in Spring 2000.)<br />
Great News<br />
Regarding Insurance<br />
You may have read previously that life insurance is<br />
available to Pw<strong>MS</strong>. Now I have definite proof.<br />
I was contacted by a Pw<strong>MS</strong> who is on Avonex. To my<br />
delight <strong>and</strong> surprise, she was approved for life insurance<br />
at a much lower premium than even I had expected.<br />
This is magnificent! It proves that insurance companies<br />
are now starting (emphasise starting) to look at <strong>MS</strong> as<br />
a disease that is manageable <strong>and</strong> not necessarily life<br />
threatening.<br />
As an aside to this, I also have access to disability<br />
insurance in limited situations. If you are working <strong>and</strong><br />
the place of employment has at least five employees,<br />
then we may be able to assist in obtaining disability<br />
cover through s<strong>up</strong>erannuation. Conditions do apply, <strong>and</strong><br />
you will need to contact my office to underst<strong>and</strong> these<br />
conditions. But at least it is available.<br />
I strongly encourage all Pw<strong>MS</strong> to examine their<br />
insurance situation. Not just their own, but anyone<br />
financially linked to them (such as spouse, partner,<br />
business partner etc). The need for insurance of these<br />
people is vital, especially if you are a Pw<strong>MS</strong> <strong>and</strong> may find<br />
life financially difficult without that person.<br />
If you feel you need to review your insurance, please<br />
contact me as I can probably assist.<br />
Todd Cameron is a proper authority holder with AMP<br />
Financial Planning, Licensed securities dealer, A.C.N. no.<br />
051 208 327. He can be contacted on 02 9739 8620 or<br />
tcameron@insureinvest.com.au<br />
Annoucing the Book!<br />
It’s a revolutionary breakthrough in technology: no<br />
wires, no electric circuits, no batteries, nothing to be<br />
connected or switched on. It’s so easy to use even a<br />
child can operate it. Just lift its cover. Compact <strong>and</strong><br />
portable, it can be used anywhere—even sitting in an<br />
armchair by the fire—yet it is powerful enough to hold<br />
as much information as a CD-ROM.<br />
Here’s how it works: each BOOK is constructed of<br />
sequentially numbered sheets of paper (recyclable),<br />
each capable of holding thous<strong>and</strong>s of bits of<br />
information. These pages are locked to<strong>get</strong>her with a<br />
custom-fit device called a binder which keeps the<br />
sheets in their correct sequence. By using both sides of<br />
each sheet, manufacturers are able to cut costs in half.<br />
Each sheet is scanned optically, registering information<br />
directly into your brain. A flick of the finger takes you to<br />
the next sheet. The book may be taken <strong>up</strong> at any time<br />
<strong>and</strong> used by merely opening it. The “browse” feature<br />
allows you to move instantly to any sheet, <strong>and</strong> move<br />
forward <strong>and</strong> backward as you wish. Most come with an<br />
“index” feature, which pinpoints the exact location of<br />
any selected information for instant retrieval.<br />
An optional “BOOKmark” accessory allows you to<br />
open the BOOK to the exact place you left it in a<br />
previous session—even if the BOOK has been closed.<br />
BOOKmarks fit universal design st<strong>and</strong>ards; thus a single<br />
BOOKmark can be used in BOOKs by various<br />
manufacturers.<br />
Portable, durable <strong>and</strong> affordable, the BOOK is the<br />
entertainment wave of the future, an many new titles<br />
are expected soon, due to the surge in popularity of its<br />
programming tool, the Portable Erasable-Nib Cryptic<br />
Intercommunication Language Stylus.<br />
MAGSCENE – INTERCOMMUNICATION FOR PEOPLE WITH <strong>MS</strong> – NEW SOUTH WALES